These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1929278)

  • 21. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
    Yassien M; Khardori N
    Diagn Microbiol Infect Dis; 2001 Jul; 40(3):79-89. PubMed ID: 11502373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
    Maple PA; Hamilton-Miller JM; Brumfitt W
    Antimicrob Agents Chemother; 1991 Feb; 35(2):345-50. PubMed ID: 1827242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
    Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
    J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus.
    van Rensburg CE; Joone G; Anderson R
    J Med Microbiol; 1990 May; 32(1):15-7. PubMed ID: 2111406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB; Sokolova VI
    Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
    Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terpene-Functionalized Fluoroquinolones as Potential Antimicrobials: Synthesis and Properties.
    Izmest'ev ES; Pestova SV; Kolesnikova AI; Baidamshina DR; Kayumov AR; Rubtsova SA
    ChemMedChem; 2023 Dec; 18(24):e202300358. PubMed ID: 37872856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
    Debbia EA; Pesce A; Schito GC
    Am J Med; 1992 Apr; 92(4A):45S-47S. PubMed ID: 1316070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections.
    Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
    J Dermatol; 1995 Feb; 22(2):153-5. PubMed ID: 7722093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elimination of virulence plasmids of Yersinia pseudotuberculosis as affected by fluoroquinolones].
    Zaĭtseva EA; Shubin FN; Besednova NN
    Antibiot Khimioter; 1996 Jun; 41(6):34-8. PubMed ID: 9054327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.
    Kojima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1123-7. PubMed ID: 2393270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The postantibiotic effect of fusidic acid against gram-positive bacteria.
    Munckhof WJ; Turnidge JD
    J Antimicrob Chemother; 1997 Sep; 40(3):433-6. PubMed ID: 9338499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.
    Al-Nawas B; Shah PM
    J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
    Syrjälä H; Schildt R; Räisäinen S
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):68-70. PubMed ID: 1864276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus.
    Filocamo A; Bisignano C; D'Arrigo M; Ginestra G; Mandalari G; Galati EM
    Lett Appl Microbiol; 2011 Aug; 53(2):193-7. PubMed ID: 21609344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.
    Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
    Chemotherapy; 1991; 37(3):218-23. PubMed ID: 1889309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.
    Okuda J; Okamoto S; Takahata M; Nishino T
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2288-93. PubMed ID: 1666495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.